• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec13
Wall Street Zen Downgrades Teva Pharmaceutical to Buy
07:11
Dec12
Teva to Release Q4 2025 Financial Results
21:30
Dec11
Teva Extends $2.5 Billion Revolving Credit Facility and Amends Financial Covenants
21:32
Teva Pharmaceutical Insiders Sold $3,311,126 in Shares
21:18
Dec10
Teva Pharmaceuticals Removes Over 200 Improper Patents Under FTC Pressure
16:51
Menora Mivtachim Holdings Increases Teva Pharmaceutical Holdings
12:59

Schedules & Filings

Schedules
Filings
Jan28
Earning Release(EST)

FY2025 Q4 Earning Release

Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 4.48 B, Net Income 433 M, EPS 0.37

Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.176 B, Net Income 282 M, EPS 0.24

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More